(Q27139739)
English
alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->3)-[alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)]-beta-D-GlcpNAc
chemical compound
- Neu5Acalpha2-3Galbeta1-3(Neu5Acalpha2-3Galbeta1-4)GlcNAcbeta
- N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->3)-[N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->4)]-N-acetyl-beta-D-glucosamine
- alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-[alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)]-beta-D-GlcNAc
- Neu5Aca2-3Galb1-4(Neu5Aca2-3Galb1-3)GlcNAcb
Statements
1,127.386±0 dalton
1 reference
Neu5Acalpha2-3Galbeta1-3(Neu5Acalpha2-3Galbeta1-4)GlcNAcbeta (English)
7 October 2016
C₄₂H₆₉N₃O₃₂
1 reference
Neu5Acalpha2-3Galbeta1-3(Neu5Acalpha2-3Galbeta1-4)GlcNAcbeta (English)
7 October 2016
CC(=O)NC1C(CC(OC1C(C(CO)O)O)(C(=O)O)OC2C(C(OC(C2O)OC3C(OC(C(C3OC4C(C(C(C(O4)CO)O)OC5(CC(C(C(O5)C(C(CO)O)O)NC(=O)C)O)C(=O)O)O)NC(=O)C)O)CO)CO)O)O
1 reference
Neu5Acalpha2-3Galbeta1-3(Neu5Acalpha2-3Galbeta1-4)GlcNAcbeta (English)
7 October 2016
CC(=O)N[C@@H]1[C@H](C[C@@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)O)O[C@H]2[C@H]([C@H](O[C@H]([C@@H]2O)O[C@@H]3[C@H](O[C@H]([C@@H]([C@H]3O[C@H]4[C@@H]([C@H]([C@H]([C@H](O4)CO)O)O[C@@]5(C[C@@H]([C@H]([C@@H](O5)[C@@H]([C@@H](CO)O)O)NC(=O)C)O)C(=O)O)O)NC(=O)C)O)CO)CO)O)O
1 reference
Neu5Acalpha2-3Galbeta1-3(Neu5Acalpha2-3Galbeta1-4)GlcNAcbeta (English)
7 October 2016
Identifiers
1 reference
2 references
Neu5Acalpha2-3Galbeta1-3(Neu5Acalpha2-3Galbeta1-4)GlcNAcbeta (English)
7 October 2016
1 reference
(6R)-5-Acetamido-3,5-dideoxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]-beta-L-threo-hex-2-ulopyranonosyl-(2->3)-beta-D-galactopyranosyl-(1->3)-[(6R)-5-acetamido-3,5-dideoxy-6-[(1R,2R)-1,2,3-trihydroxypropyl] (English)
7 October 2016
2 references
Neu5Acalpha2-3Galbeta1-3(Neu5Acalpha2-3Galbeta1-4)GlcNAcbeta (English)
7 October 2016
2 references
1 reference